ArticleExperimental and therapeutic medicine2025
Diagnosis and treatment of Von Hippel-Lindau syndrome: A case series.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of the present case report was to explore the clinical approaches to diagnosing and managing Von Hippel-Lindau (VHL) syndrome. A retrospective review was performed on the clinical presentations, imaging findings and family genetic histories of four patients diagnosed with VHL syndrome. Their clinical features and treatment strategies were systematically analyzed. The cohort comprised of four patients, one male and three female patients, with ages at initial onset ranging from 24 to 38 years, and a median age of 32.3 years. None of the patients reported a family history of the condition, and all patients showed central nervous system hemangioblastomas and pancreatic cysts. The results of the present study demonstrated that VHL syndrome presents with a broad spectrum of clinical manifestations, often with considerable time intervals between the involvement of different organ systems. The study highlights that the presence of tumors in the central nervous system, pancreas, kidneys or other organs should prompt consideration of VHL syndrome. Accurate diagnosis relies on a thorough checking of medical history, comprehensive imaging studies and confirmatory genetic testing. The marked clinical heterogeneity and phenotypic complexity of VHL syndrome pose substantial diagnostic challenges for both clinicians and patients. The present study systematically characterizes the clinical manifestations and radiological signatures of VHL syndrome, providing actionable insights to enhance diagnostic precision and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.